Cargando…
Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility
This commentary attempts to discuss the required standardization of circulating tumor DNA (ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the metastatic setting of solid tumors.
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543969/ https://www.ncbi.nlm.nih.gov/pubmed/35302663 http://dx.doi.org/10.1002/cncr.34168 |
| _version_ | 1784804495225520128 |
|---|---|
| author | Brenner Thomsen, Caroline Dandanell Juul, Amanda Lefèvre, Anna Cecilie Glismand Truelsen, Christina Dizdarevic, Edina Ryssel, Heidi Mathilde Kjær, Ina Lycke Wind, Karen Callesen, Louise Bach Faaborg Larsen, Louise Støchkel Frank, Malene Fredslund Andersen, Rikke Garm Spindler, Karen‐Lise Jakobsen, Anders |
| author_facet | Brenner Thomsen, Caroline Dandanell Juul, Amanda Lefèvre, Anna Cecilie Glismand Truelsen, Christina Dizdarevic, Edina Ryssel, Heidi Mathilde Kjær, Ina Lycke Wind, Karen Callesen, Louise Bach Faaborg Larsen, Louise Støchkel Frank, Malene Fredslund Andersen, Rikke Garm Spindler, Karen‐Lise Jakobsen, Anders |
| author_sort | Brenner Thomsen, Caroline |
| collection | PubMed |
| description | This commentary attempts to discuss the required standardization of circulating tumor DNA (ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the metastatic setting of solid tumors. |
| format | Online Article Text |
| id | pubmed-9543969 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95439692022-10-14 Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility Brenner Thomsen, Caroline Dandanell Juul, Amanda Lefèvre, Anna Cecilie Glismand Truelsen, Christina Dizdarevic, Edina Ryssel, Heidi Mathilde Kjær, Ina Lycke Wind, Karen Callesen, Louise Bach Faaborg Larsen, Louise Støchkel Frank, Malene Fredslund Andersen, Rikke Garm Spindler, Karen‐Lise Jakobsen, Anders Cancer Commentary This commentary attempts to discuss the required standardization of circulating tumor DNA (ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the metastatic setting of solid tumors. John Wiley and Sons Inc. 2022-03-18 2022-06-01 /pmc/articles/PMC9543969/ /pubmed/35302663 http://dx.doi.org/10.1002/cncr.34168 Text en © 2022 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Commentary Brenner Thomsen, Caroline Dandanell Juul, Amanda Lefèvre, Anna Cecilie Glismand Truelsen, Christina Dizdarevic, Edina Ryssel, Heidi Mathilde Kjær, Ina Lycke Wind, Karen Callesen, Louise Bach Faaborg Larsen, Louise Støchkel Frank, Malene Fredslund Andersen, Rikke Garm Spindler, Karen‐Lise Jakobsen, Anders Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility |
| title | Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility |
| title_full | Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility |
| title_fullStr | Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility |
| title_full_unstemmed | Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility |
| title_short | Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility |
| title_sort | reporting on circulating tumor dna monitoring in metastatic cancer—from clinical validity to clinical utility |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543969/ https://www.ncbi.nlm.nih.gov/pubmed/35302663 http://dx.doi.org/10.1002/cncr.34168 |
| work_keys_str_mv | AT brennerthomsencaroline reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT dandanelljuulamanda reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT lefevreannacecilie reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT glismandtruelsenchristina reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT dizdarevicedina reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT rysselheidi reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT mathildekjærina reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT lyckewindkaren reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT callesenlouisebach reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT faaborglarsenlouise reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT støchkelfrankmalene reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT fredslundandersenrikke reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT garmspindlerkarenlise reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility AT jakobsenanders reportingoncirculatingtumordnamonitoringinmetastaticcancerfromclinicalvaliditytoclinicalutility |